NRC Health (NRC) stock
Close on Nov 12, 2026Market cap $589.27MP/E –Yield 1.95%
NRC Health grew revenue 3.4% to $143.79M over the twelve months to Sep 30, 2026. Operating income fell 42.2% to $15.91M, moving the operating margin from 19.8% to 11.1%. Free cash flow was $18.45M, up 58.7% from a year earlier. At the latest close the market valued the company at $589.27M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $589.27M
- P/E ratio
- –
- Price to sales
- 4.10
- Price to book
- –
- Dividend yield
- 1.95%
- Free cash flow yield
- 3.13%
Fundamentals
- Revenue
- $143.79M
- EPS, diluted
- $50.00
- Free cash flow
- $18.45M
- Book value per share
- -$0.42
- Diluted shares
- 22M
Trading
- Next earnings
- Feb 2, 2027 (estimated, before the open)
- Previous close
- $26.86
- Open
- $26.86
- Day's range
- $26.36 – $27.60
- Volume
- 93,360
- Average volume (20 days)
- 114,598
- Index membership
- Russell 2000, Russell 3000
- Beta (5 years)
- 0.51
- 52-week range
- $11.73 – $27.41
- RSI (14 days)
- 70.0
- Volatility (1 year)
- 57.9%
- Relative volume
- 1.12×
- WACC
- 6.9%
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | NRC | S&P 500 | Difference | NRC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +30.5% | -2.7% | +33.2 pts | ||
| 3 months | +30.3% | -1.7% | +32.0 pts | ||
| Year to date | +45.5% | +11.9% | +33.6 pts | ||
| 1 year | +78.5% | +12.0% | +66.5 pts | ||
| 3 years | -30.9% | +78.2% | −109.0 pts | -11.6% | +21.2% |
| 5 years | -36.0% | +73.2% | −109.3 pts | -8.6% | +11.6% |
| 10 years | +106.1% | +309.6% | −203.5 pts | +7.5% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases NRC Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
About NRC Health
Services-Commercial Physical & Biological Research
National Research Corporation, doing business as NRC Health, provides experience management solutions, data analytics, and actionable insights for the healthcare sector. The company's digital offerings span four primary categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience. In addition, its Governance Solutions, operating as The Governance Institute, deliver advisory services, research, conferences, and publications. These solutions assist healthcare organizations in capturing constituent feedback, evaluating brand perception, engaging clinical staff, and strengthening executive governance. Customers include healthcare systems, hospital boards, executives, and physician leadership across the care continuum.
Company profile, executives and historyNRC Health stock: common questions
What is NRC Health's stock price?
NRC closed at $26.64 on Nov 12, 2026, down 0.82% on the day. Over the past 52 weeks it traded between $11.73 and $27.41.
What is NRC Health's market cap?
NRC Health was worth $589.27M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
How much revenue does NRC Health make?
NRC Health reported revenue of $143.79M for the twelve months to Sep 30, 2026, up 3.4% from a year earlier.
Does NRC Health pay a dividend?
Yes. NRC Health paid $0.52 per share over the last twelve months, a yield of 1.95% at the latest price.
When does NRC Health report earnings next?
NRC Health is expected to report Q4 FY2026 results on Feb 2, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has NRC stock performed over the past year?
Including dividends, NRC returned +78.5% over the past year, against +12.0% for the S&P 500.
How many NRC shares are sold short?
1M shares were sold short at the latest FINRA report, 6.26% of the float, or 7.1 days of average trading volume.
Who are NRC Health's competitors?
Companies most similar to NRC Health by business, industry and size include FOXO, MXCT, DH, NEO, OABI.
See a number that looks wrong?